登录

David Dardashti的Ibogaine用矩阵理论重塑治疗软件

Ibogaine By David Dardashti Reshapes Treatment Software With Matrix Theory

GlobeNewswire | 2024-05-10 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


MIAMI, May 09, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the next stage of their treatment software's development, which will incorporate matrix theory through the use of a Python script and multidimensional array. The new programming sequences allow the company to maximize dosing efficiency with an easy-to-use system.

迈阿密,2024年5月9日(环球通讯社)--DavidDardashti的Ibogaine骄傲地宣布了他们治疗软件开发的下一阶段,该软件将通过使用Python脚本和多维数组来结合矩阵理论。新的编程序列使该公司能够通过易于使用的系统最大限度地提高剂量效率。

David Dardashti, the founder and CEO of Ibogaine, stated, “Our program is already incredibly efficient, but adding the matrix theory module will greatly improve our intake process and maximize our capabilities. We’re incredibly excited to see the results of this new development.” The software optimizations involve database management with the use of arrays to manage previous patient dosing information as well as to allow for new functions with variables that rely on recent trends.

Ibogaine的创始人兼首席执行官大卫·达达什蒂(DavidDardashti)表示:“我们的程序已经非常高效,但添加矩阵理论模块将极大地改善我们的摄入过程并最大限度地发挥我们的能力。我们非常高兴看到这一新开发的结果。”软件优化涉及数据库管理,使用阵列管理以前的患者剂量信息,并允许使用依赖于最新趋势的变量实现新功能。

This will help the software to facilitate the transition between dosages for men and women in a smooth and efficient manner, without the need to alter individual variables. Ibogaine, a pharmaceutical company, has implemented a new programming sequence that uses matrix theory and database management to maximize dosing efficiency and streamline the intake process.

这将有助于该软件以平稳有效的方式促进男性和女性剂量之间的转换,而无需改变个体变量。制药公司Ibogaine实施了一种新的编程序列,该序列使用矩阵理论和数据库管理来最大程度地提高给药效率并简化摄入过程。

Ibogaine By David Dardashti is proud to be paving the way for the future of treatment software with the incorporation of matrix theory, and looks forward to continuing to push the boundaries with their innovative new programming. Gavriel Dardashti+17869301880gavriel@ibogaineclinic.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/28dd3918-e675-40ac-95a7-41d0464a2f7d .

大卫·达达什蒂(DavidDardashti)的《伊博加因》(Ibogaine)很自豪地为矩阵理论的结合为治疗软件的未来铺平了道路,并期待着通过他们创新的新编程继续推动边界。加夫里尔·达达什蒂+17869301880gavriel@ibogaineclinic.com有关此公告的照片,请访问https://www.globenewswire.com/NewsRoom/AttachmentNg/28dd3918-e675-40ac-95a7-41d0464a2f7d。

推荐阅读

Hims&Hers Health将复合GLP-1注射液加入减肥计划

CNBC 2024-05-20 21:15

Lisata Therapeutics获得欧洲药品管理局对Certepetide治疗胰腺癌症的儿科调查计划豁免

BioSpace 2024-05-20 21:09

eFFECTOR Therapeutics将与Dana-Farber癌症研究所合作进行一项研究者赞助的2期临床试验,评估唑他芬作为ER+子宫内膜癌症的联合治疗

BioSpace 2024-05-20 21:08

GlobeNewswire

8184篇

最近内容 查看更多

美因茨生物医药公司在消化道疾病周上获得杰出海报,为该公司计划中的美国食品药品监督管理局试验定位

7 小时后

Scorpius Holdings宣布在圣安东尼奥进行重大扩建,新建最先进的存储和测试设施

7 小时后

NV5通过收购myBIMteam加强基于订阅的服务

7 小时后

产业链接查看更多

所属赛道

健康医疗大数据
动脉橙产业智库梳理了:健康医疗大数据相关公司关联事件100+;相关政策100+;近8年投融资总额超过94亿美元;产业图谱、TOP公司作战地图等分析维度,并将持续更新。因国内外关于健康医疗大数据定义存在分歧,故动脉橙产业智库重点梳理国内医疗健康大数据公司。